- Home
- PTGX vs RHI Comparison
PTGX vs RHI Comparison
Compare PTGX & RHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTGX
- RHI
- Stock Information
- Founded
- PTGX 2006
- RHI 1948
- Country
- PTGX United States
- RHI United States
- Employees
- PTGX 130
- RHI N/A
- Industry
- PTGX Biotechnology: Pharmaceutical Preparations
- RHI Professional Services
- Sector
- PTGX Health Care
- RHI Consumer Discretionary
- Exchange
- PTGX Nasdaq
- RHI Nasdaq
- Market Cap
- PTGX 5.0B
- RHI 3.3B
- IPO Year
- PTGX 2016
- RHI N/A
- Fundamental
- Price
- PTGX $79.54
- RHI $26.24
- Analyst Decision
- PTGX Strong Buy
- RHI Sell
- Analyst Count
- PTGX 9
- RHI 7
- Target Price
- PTGX $86.22
- RHI $40.00
- AVG Volume (30 Days)
- PTGX 1.3M
- RHI 2.7M
- Earning Date
- PTGX 11-06-2025
- RHI 10-22-2025
- Dividend Yield
- PTGX N/A
- RHI 8.95%
- EPS Growth
- PTGX N/A
- RHI N/A
- EPS
- PTGX 0.72
- RHI 1.54
- Revenue
- PTGX $209,217,000.00
- RHI $5,458,499,000.00
- Revenue This Year
- PTGX N/A
- RHI N/A
- Revenue Next Year
- PTGX $140.23
- RHI $0.90
- P/E Ratio
- PTGX $110.77
- RHI $17.12
- Revenue Growth
- PTGX N/A
- RHI N/A
- 52 Week Low
- PTGX $33.31
- RHI $25.22
- 52 Week High
- PTGX $93.25
- RHI $78.41
- Technical
- Relative Strength Index (RSI)
- PTGX 62.21
- RHI 26.98
- Support Level
- PTGX $75.44
- RHI $25.22
- Resistance Level
- PTGX $80.43
- RHI $26.29
- Average True Range (ATR)
- PTGX 2.61
- RHI 1.09
- MACD
- PTGX -0.23
- RHI -0.15
- Stochastic Oscillator
- PTGX 89.38
- RHI 17.81
About PTGX Protagonist Therapeutics Inc.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
About RHI Robert Half Inc.
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry. The firm generates annual revenue of around $7 billion.